1. A crucial list of pathogens. Issue 3 (March 2018) Authors: Tillotson, Glenn Journal: Lancet infectious diseases Issue: Volume 18:Issue 3(2018) Page Start: 234 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Analysis of Pooled Phase 3 Safety Data for Delafloxacin in Acute Bacterial Skin and Skin Structure Infections. (8th April 2019) Authors: Bassetti, Matteo; Hooper, David; Tillotson, Glenn Journal: Clinical infectious diseases Issue: Volume 68(2019)Supplement 3 Page Start: S233 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Antibiotic Treatment Failure and Associated Outcomes Among Adult Patients With Community-Acquired Pneumonia in the Outpatient Setting: A Real-world US Insurance Claims Database Study. (26th February 2020) Authors: Tillotson, Glenn; Lodise, Thomas; Classi, Peter; Mildvan, Donna; McKinnell, James A Journal: Open forum infectious diseases Issue: Volume 7:Number 3(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Antimicrobial Management of Respiratory Infections in Severe Acute Respiratory Syndrome Coronavirus 2 Patients: Clinical and Antimicrobial Stewardship Programs Conundrums. (26th October 2020) Authors: Goldstein, Ellie J C; Tillotson, Glenn; Redell, Mark Journal: Open forum infectious diseases Issue: Volume 7:Number 11(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Antimicrobial resistance: what's needed. Issue 7 (July 2015) Authors: Tillotson, Glenn Journal: Lancet infectious diseases Issue: Volume 15:Issue 7(2015:Jul.) Page Start: 758 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Antimicrobial resistance: what's needed. Issue 7 (July 2015) Authors: Tillotson, Glenn Journal: Lancet infectious diseases Issue: Volume 15:Issue 7(2015:Jul.) Page Start: 758 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Colistin for the treatment of multidrug-resistant infections. Issue 11 (November 2018) Authors: LaPlante, Kerry; Cusumano, Jaclyn; Tillotson, Glenn Journal: Lancet infectious diseases Issue: Volume 18:Issue 11(2018) Page Start: 1174 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. COVID-19 corollary: the changing role of a hospital epidemiologist in the new world. Issue 1 (2nd January 2021) Authors: Chopra, Teena; Levy, Phillip; Tillotson, Glenn; Sobel, Jack Journal: Expert review of anti-infective therapy Issue: Volume 19:Issue 1(2021) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Delafloxacin: an improved fluoroquinolone developed through advanced molecular engineering. (August 2018) Authors: Bassetti, Matteo; Righi, Elda; Pecori, Davide; Tillotson, Glenn Journal: Future microbiology Issue: Volume 13:Number 10(2018) Page Start: 1081 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Global travel and Gram-negative bacterial resistance; implications on clinical management. Issue 2 (1st February 2021) Authors: Theriault, Nicolette; Tillotson, Glenn; Sandrock, Christian E Journal: Expert review of anti-infective therapy Issue: Volume 19:Issue 2(2021) Page Start: 181 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗